Alexander Wurzer

990 total citations
31 papers, 713 citations indexed

About

Alexander Wurzer is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Alexander Wurzer has authored 31 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Alexander Wurzer's work include Radiopharmaceutical Chemistry and Applications (24 papers), Prostate Cancer Treatment and Research (23 papers) and Peptidase Inhibition and Analysis (11 papers). Alexander Wurzer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Prostate Cancer Treatment and Research (23 papers) and Peptidase Inhibition and Analysis (11 papers). Alexander Wurzer collaborates with scholars based in Germany, Italy and Hungary. Alexander Wurzer's co-authors include Hans‐Jürgen Wester, Matthias Eiber, Roswitha Beck, Wolfgang Weber, Johannes Notni, Markus Schwaiger, Alexander Schmidt, Markus Kroenke, Thomas Horn and Isabel Rauscher and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Alexander Wurzer

31 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Wurzer Germany 17 497 449 230 120 62 31 713
Nadine Colpo Canada 18 534 1.1× 217 0.5× 307 1.3× 166 1.4× 20 0.3× 41 766
Eleni Gourni Germany 18 612 1.2× 306 0.7× 653 2.8× 187 1.6× 40 0.6× 42 1.2k
Samantha Y.A. Terry United Kingdom 19 474 1.0× 186 0.4× 315 1.4× 219 1.8× 67 1.1× 49 851
Sabine Zitzmann-Kolbe Germany 14 286 0.6× 193 0.4× 228 1.0× 207 1.7× 18 0.3× 33 627
Martina Weineisen Germany 7 742 1.5× 754 1.7× 250 1.1× 78 0.7× 16 0.3× 12 942
Irina Velikyan Sweden 15 736 1.5× 237 0.5× 413 1.8× 185 1.5× 18 0.3× 29 982
Tammy L. Rold United States 20 875 1.8× 298 0.7× 585 2.5× 263 2.2× 62 1.0× 34 1.2k
Janneke D.M. Molkenboer‐Kuenen Netherlands 16 535 1.1× 267 0.6× 414 1.8× 211 1.8× 13 0.2× 33 956
Ute Hennrich Germany 8 717 1.4× 474 1.1× 436 1.9× 181 1.5× 11 0.2× 12 1.1k

Countries citing papers authored by Alexander Wurzer

Since Specialization
Citations

This map shows the geographic impact of Alexander Wurzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Wurzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Wurzer more than expected).

Fields of papers citing papers by Alexander Wurzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Wurzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Wurzer. The network helps show where Alexander Wurzer may publish in the future.

Co-authorship network of co-authors of Alexander Wurzer

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Wurzer. A scholar is included among the top collaborators of Alexander Wurzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Wurzer. Alexander Wurzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wurzer, Alexander, Sebastian Fischer, Markus Schwaiger, et al.. (2024). Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies. EJNMMI Radiopharmacy and Chemistry. 9(1). 18–18. 6 indexed citations
2.
Ilhan, Harun, Markus Kroenke, Alexander Wurzer, et al.. (2022). 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study. Journal of Nuclear Medicine. 63(8). 1208–1214. 4 indexed citations
3.
Kroenke, Markus, Thomas Horn, Bernhard Haller, et al.. (2022). Validation of18F-rhPSMA-7 and18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer. Journal of Nuclear Medicine. 63(12). 1809–1814. 15 indexed citations
4.
Knorr, Karina, So Won Oh, Martin Krönke, et al.. (2022). Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3. EJNMMI Research. 12(1). 8–8. 6 indexed citations
5.
Langbein, Thomas, Hui Wang, Isabel Rauscher, et al.. (2022). Utility of 18F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology. Journal of Nuclear Medicine. 63(9). 1334–1342. 19 indexed citations
6.
Wurzer, Alexander, Sebastian Fischer, Roswitha Beck, et al.. (2022). Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer. Journal of Nuclear Medicine. 63(10). 1489–1495. 27 indexed citations
7.
Langbein, Thomas, Alexander Wurzer, Andrei Gafita, et al.. (2021). The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical Positron Emission Tomography Data. Journal of Nuclear Medicine. 63(5). jnumed.121.262471–jnumed.121.262471. 7 indexed citations
8.
Feuerecker, Benedikt, Maythinee Chantadisai, Robert Tauber, et al.. (2021). Pretherapeutic Comparative Dosimetry of177Lu-rhPSMA-7.3 and177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 63(6). 833–839. 22 indexed citations
9.
Kroenke, Markus, Thomas Horn, Jan C. Peeken, et al.. (2020). Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity. Journal of Nuclear Medicine. 62(8). 1082–1088. 45 indexed citations
10.
Wurzer, Alexander, Michael Herz, Calogero D’Alessandria, et al.. (2020). Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T. Journal of Nuclear Medicine. 62(8). 1106–1111. 21 indexed citations
11.
Wurzer, Alexander, et al.. (2020). Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics. EJNMMI Research. 10(1). 149–149. 32 indexed citations
12.
Chantadisai, Maythinee, Martin Krönke, Isabel Rauscher, et al.. (2020). Positive predictive value and correct detection rate of 18F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard. Journal of Nuclear Medicine. 62(7). jnumed.120.255661–jnumed.120.255661. 6 indexed citations
13.
Eiber, Matthias, Markus Kroenke, Alexander Wurzer, et al.. (2019). 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy. Journal of Nuclear Medicine. 61(5). 696–701. 60 indexed citations
14.
Oh, So Won, Alexander Wurzer, Eugene Teoh, et al.. (2019). Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer. Journal of Nuclear Medicine. 61(5). 702–709. 38 indexed citations
15.
Kroenke, Markus, Alexander Wurzer, Kristina Schwamborn, et al.. (2019). Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer. Journal of Nuclear Medicine. 61(5). 710–715. 32 indexed citations
16.
Wurzer, Alexander, Alexander Schmidt, Roswitha Beck, et al.. (2019). Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors. Journal of Nuclear Medicine. 61(5). 735–742. 95 indexed citations
17.
Maurer, Tobias, Markus Kroenke, Alexander Wurzer, et al.. (2019). 18F-rhPSMA7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy. European Urology Supplements. 18(1). e684–e684. 5 indexed citations
19.
Schottelius, Margret, Alexander Wurzer, Roswitha Beck, et al.. (2018). Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer. Journal of Nuclear Medicine. 60(1). 71–78. 76 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026